Pharmaceutical rebate debated in Germany

05/1/2013 | Financial Times (tiered subscription model)

The expiration of Germany's 16% rebate for pharmaceuticals at the end of 2013 is prompting debate about its necessity. The country's Statutory Health Insurance funds, which benefit from the rebate, made a huge surplus last year, according to price consultant Andreas Guhl. Contracts will expire Dec. 31, so a decision will likely be made about August to October. "I can't see the likelihood of the rebate disappearing completely," Guhl said.

View Full Article in:

Financial Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI